# Kennedy Lewis Investment Management

> Kennedy Lewis Investment Management is a VC fund backing Health Care. See 16 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: New York, United States
- Total investments: 16
- Last investment: Nov 2025
- Lead investor: 69%
- Fund size: $4.1B
- Last fund: Nov 2023
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/kennedy-lewis-investment-management-llc
- Website: https://klimllc.com/

Kennedy Lewis Investment Management is a VC fund in New York focused on Health Care and Real Estate. Kennedy Lewis investment strategy is to focus on event-driven situations in which a catalyst may unlock value independent of overall market movements. The fund will generally target middle market companies that are facing some form of disruption. These investments will typically be associated with companies that have unsustainable capitalstructures and/or lack access to traditional sources of capital. Through a rigorous deep fundamental credit approach, complemented by established sector views, the construction of the portfolio will concentrate on investments in sectors where capital can be deployed tactically to provide capital structure stability or at times fund growth. The fund’s investments tend to be highly structured, are often associated with complexity, have the presence of ample asset coverage and generally require a contrarian mindset.

## Contacts

5 contacts available for Kennedy Lewis Investment Management. Shizune tracks 4 team members at Kennedy Lewis Investment Management. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/kennedy-lewis-investment-management?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 3 | 19% |
| Real Estate | 3 | 19% |
| Biotechnology | 3 | 19% |
| Medical Device | 3 | 19% |
| Financial Services | 3 | 19% |

36 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Post-IPO Debt | 4 | 25% |
| Series A | 2 | 13% |
| Series C | 2 | 13% |
| Series D | 2 | 13% |
| Venture - Series Unknown | 2 | 13% |

9 stages tracked in total.

### Country

| Country | Investments | Share |
| --- | --- | --- |
| United States | 12 | 75% |
| Germany | 1 | 6% |
| Australia | 1 | 6% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Ben Schryber | Partner | 0 | — |
| Darren L. Richman | Managing Partner | 0 | — |
| David K. Chene | Co-Founder, Co-Portfolio Manager & Co-Managing Partner | 1 | — |
| Thomas DeSouza | Managing Director | 0 | — |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Onchilles Pharma | Onchilles Pharma is a biotechnology company developing first-in-class biologics therapies for the treatment of cancer. The company's drug selectively targets cancer cells and is non-toxic to normal cells and tissues, helping medical professionals treat cancer patients efficiently.It was founded in 2017 and is headquartered in San Diego,California. | $25M | Series A | Nov 07, 2025 |  |
| Kennedy Lewis Loan Management | Kennedy Lewis Loan Management is a provider of collateral loan obligation (CLO) services. |  | Secondary Market | Sep 30, 2025 |  |
| Monomoy Properties | Monomoy Properties specializing in net leased assets, specifically class B & C warehouse, distribution, and light manufacturing assets. | $100M | Debt Financing | Jul 31, 2025 |  |
| Taylor Morrison | Taylor Morrison has been helping families create memories for more than a century. When you've been doing something that long you learn a few things. You learn the right way to build. You learn that people matter. And you learn that the real staying power is in giving people a home that they want and one you know is built to last. That lastone's pretty important. | $3B | Post-IPO Debt | Jul 23, 2025 |  |
| Douglas Elliman Real Estate | Established in 1911, Douglas Elliman has grown to become the largest regional and the nation's fourth largest real estate company, with a current network of more than 5,000 agents in over 70 offices throughout Manhattan, Brooklyn, Queens, Long Island (including the Hamptons and North Fork), Westchester and Putnam Counties, as well as SouthFlorida and California. In addition, through a strategic partnership with Knight Frank Residential, Douglas Elliman's powerful network extends to 43 countries across six continents.At Douglas Elliman, they are passionate about delivering exceptional consumer experiences. By offering a complete suite of real estate services, they ensure that they meet their consumers' every need. From sales and rentals, to mortgage, new developments and title insurance, they have experts in every field to guide you skillfully from beginning to the end of your real estate journey.Douglas Elliman's outstanding track record, unique brand promise, and exceptional agent support system attract top talent, ensuring that their team of experts represents the very best in the industry. At Douglas Elliman, they believe that access to the best and most timely information can dramatically shape their decisions. Today's consumer needs a trusted resource that can separate signal from noise and help them navigate the complex process that real estate has become. With their extensive knowledge in every aspect of the field, and fueled by consumer research and insights, they are the go-to source for information and education.Their critically acclaimed website, Elliman.com, serves as a singular destination where consumers can search properties throughout the entire New York, South Florida and California markets, and access the most current market information as well as comprehensive building and neighborhood guides, among a host of interactive content. As committed to growth and innovation as they are to their consumers, they have launched AskElliman.com, their groundbreaking new web feature that facilitates open communication with consumers, allowing them to tap into the wealth of knowledge from real estate to mortgage financing, to specific neighborhoods, legal, and more. | $50M | Post-IPO Debt | Jul 02, 2024 |  |
| Brightside Health | Brightside Health is a mental health care company that helps employees better navigate and manage their financial well-being. The company makes it simple and affordable to get expert, personalized treatment for depression and anxiety all from the comfort of home. Their mission is to help people lead healthy, vital, and productive lives by making iteasy and affordable to get high-quality depression and anxiety care.Brightside was founded in 2017 and is headquartered in San Francisco, California, United States. | $33M | Series C | Mar 26, 2024 |  |
| Five Fitness Group | F45 offers consumers functional 45-minute workouts that are effective, fun and community-driven. F45 utilizes proprietary technologies: a fitness programming algorithm and a patented technology-enabled delivery platform that leverages a rich content database of over 3,900 unique functional training movements to offer new workouts each day andprovide a standardized experience across the Company’s global footprint. | $90M | Post-IPO Debt | Feb 15, 2023 |  |
| EchoNous | EchoNous is the power of intelligent medical tools for common everyday problems in healthcare. | $57M | Series D | Sep 23, 2022 |  |
| Sanctuary Wealth | Sanctuary Wealth is a financial services industry. | $175M | Convertible Note | Jul 13, 2022 |  |
| Impulse Dynamics | Impulse Dynamics is a medical device company dedicated to offering innovative solutions for treatment of Chronic Heart Failure (CHF). The Company’s developments are based on its proprietary technology for administering Cardiac Contractility Modulation therapy. This form of treatment has been shown in European clinical trials to produce an immediateand powerful modulating effect on cardiac cells, resulting in clinically meaningful increases incardiac performance.Impulse Dynamics is spearheaded by a team of professionals including, scientists, physicians, and engineers. The Company carries out research programs in major universities and hospitals throughout the world, and is currently engaged in clinical trials in Europe and in the United States. The Optimizer with Cardiac Contractility Modulation therapy, is CE marked. See Clinical Data for more information. | $101M | Venture - Series Unknown | May 12, 2022 |  |

10 of 16 investments shown.

## Co-investors
- [Abiomed](https://shizune.co/investors/profile/abiomed) — VC Fund, 2 deals together
- [S32](https://shizune.co/investors/profile/section-32) — VC Fund, 2 deals together
- [ACME Capital](https://shizune.co/investors/profile/acme-capital) — VC Fund, 1 deal together
- Acorn — VC Fund, 1 deal together
- Alger — VC Fund, 1 deal together
- Amzak Health Investors — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [BNP Paribas](https://shizune.co/investors/profile/bnp-paribas) — VC Fund
- [Intesa Sanpaolo](https://shizune.co/investors/profile/intesa-sanpaolo) — VC Fund
- [UniCredit](https://shizune.co/investors/profile/unicredit) — VC Fund

## FAQ

### What does Kennedy Lewis Investment Management invest in?

Kennedy Lewis Investment Management invests primarily in Health Care, Real Estate and Biotechnology startups, most often at Post-IPO Debt and Series A stage. Most of the 16 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Kennedy Lewis Investment Management?

Public channels for Kennedy Lewis Investment Management include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Kennedy Lewis Investment Management?

The team at Kennedy Lewis Investment Management includes Ben Schryber (Partner), Darren L. Richman (Managing Partner) and David K. Chene (Co-Founder, Co-Portfolio Manager & Co-Managing Partner). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co